Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Carboplatin-gemcitabine vs Cisplatin-gemcitabine in Muscle Invasive Bladder Cancer
NCT05822934Phase 3Active, not recruiting
- Sponsor
- Assiut University
- Start
- Nov 2022
- Primary completion
- Dec 2024
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 3 trial of carboplatin in urinary bladder cancer, sponsored by Assiut University. Started Nov 2022; status: active, not recruiting.
02
Drugs
carboplatin
03
Conditions
urinary bladder cancer
Beyond the preview
Go deeper on NCT05822934.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05822934.